Many stars have weighed in on injectables like Ozempic, Mounjaro and Wegovy. And with the stigma shifting, Rosie O'Donnell, Meghan Trainor, Scott Disick and others are proclaiming their benefits.

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...

Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would ...

Q: I took Wegovy for a few months last fall until I was unable to find a pharmacy that could fill my prescription. They were all out of stock. I lost 17 pounds and my A1C went from 6.5 in October to 5 ...

Persistent volatility has plagued the S&P 500 for much of 2025, prompting widespread caution among many investors amid the ...

Novo Nordisk A/S NVO shares lost 2.7% on Friday after a surprising announcement regarding changes to its executive leadership ...

Real-time index price for S&P 500 Index (INX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants who took Zepbound lost more weight than those who took Wegovy.

U.S. pharmacies that have been allowed to produce compounded copies of Wegovy and Ozempic due to a shortage of supply have been given until May 22 to stop, following a review by the U.S. Food and ...

(Reuters) -The U.S. Food and Drug Administration has accepted Novo Nordisk (NYSE:NVO)’s marketing application for an oral version of its weight-loss drug Wegovy and will decide in the fourth ...